164 related articles for article (PubMed ID: 38052179)
1. Vasculature is getting Hip(po): Hippo signaling in vascular development and disease.
Kobayashi S; Cox AG; Harvey KF; Hogan BM
Dev Cell; 2023 Dec; 58(23):2627-2640. PubMed ID: 38052179
[TBL] [Abstract][Full Text] [Related]
2. A novel role of Hippo-Yap/TAZ signaling pathway in lymphatic vascular development.
Cha B; Moon S; Kim W
BMB Rep; 2021 Jun; 54(6):285-294. PubMed ID: 33691907
[TBL] [Abstract][Full Text] [Related]
3. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.
Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY
Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452
[TBL] [Abstract][Full Text] [Related]
4. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.
Zhu J; Wu T; Lin Q
Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351
[TBL] [Abstract][Full Text] [Related]
5. Yap1 promotes sprouting and proliferation of lymphatic progenitors downstream of Vegfc in the zebrafish trunk.
Grimm L; Nakajima H; Chaudhury S; Bower NI; Okuda KS; Cox AG; Harvey NL; Koltowska K; Mochizuki N; Hogan BM
Elife; 2019 Apr; 8():. PubMed ID: 31038457
[TBL] [Abstract][Full Text] [Related]
6. Establishment of transgenic lines to monitor and manipulate Yap/Taz-Tead activity in zebrafish reveals both evolutionarily conserved and divergent functions of the Hippo pathway.
Miesfeld JB; Link BA
Mech Dev; 2014 Aug; 133():177-88. PubMed ID: 24560909
[TBL] [Abstract][Full Text] [Related]
7. TGF-β/Smads signaling pathway, Hippo-YAP/TAZ signaling pathway, and VEGF: Their mechanisms and roles in vascular remodeling related diseases.
Liu H; Sun M; Wu N; Liu B; Liu Q; Fan X
Immun Inflamm Dis; 2023 Nov; 11(11):e1060. PubMed ID: 38018603
[TBL] [Abstract][Full Text] [Related]
8. Role of the Hippo pathway and mechanisms for controlling cellular localization of YAP/TAZ.
Kwon H; Kim J; Jho EH
FEBS J; 2022 Oct; 289(19):5798-5818. PubMed ID: 34173335
[TBL] [Abstract][Full Text] [Related]
9. Complex roles of Hippo-YAP/TAZ signaling in hepatocellular carcinoma.
Shi H; Zou Y; Zhong W; Li Z; Wang X; Yin Y; Li D; Liu Y; Li M
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15311-15322. PubMed ID: 37608027
[TBL] [Abstract][Full Text] [Related]
10. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis.
Nishina H
Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740
[TBL] [Abstract][Full Text] [Related]
11. DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer.
Wang D; Li Z; Li X; Yan C; Yang H; Zhuang T; Wang X; Zang Y; Liu Z; Wang T; Jiang R; Su P; Zhu J; Ding Y
J Exp Clin Cancer Res; 2022 Jul; 41(1):219. PubMed ID: 35820928
[TBL] [Abstract][Full Text] [Related]
12. Common and Distinctive Functions of the Hippo Effectors Taz and Yap in Skeletal Muscle Stem Cell Function.
Sun C; De Mello V; Mohamed A; Ortuste Quiroga HP; Garcia-Munoz A; Al Bloshi A; Tremblay AM; von Kriegsheim A; Collie-Duguid E; Vargesson N; Matallanas D; Wackerhage H; Zammit PS
Stem Cells; 2017 Aug; 35(8):1958-1972. PubMed ID: 28589555
[TBL] [Abstract][Full Text] [Related]
13. CDK7 regulates organ size and tumor growth by safeguarding the Hippo pathway effector Yki/Yap/Taz in the nucleus.
Cho YS; Li S; Wang X; Zhu J; Zhuo S; Han Y; Yue T; Yang Y; Jiang J
Genes Dev; 2020 Jan; 34(1-2):53-71. PubMed ID: 31857346
[TBL] [Abstract][Full Text] [Related]
14. The Hippo Pathway Effectors YAP and TAZ Regulate LH Release by Pituitary Gonadotrope Cells in Mice.
Lalonde-Larue A; Boyer A; Dos Santos EC; Boerboom D; Bernard DJ; Zamberlam G
Endocrinology; 2022 Jan; 163(1):. PubMed ID: 34905605
[TBL] [Abstract][Full Text] [Related]
15. Hippo-Yap/Taz signaling: Complex network interactions and impact in epithelial cell behavior.
van Soldt BJ; Cardoso WV
Wiley Interdiscip Rev Dev Biol; 2020 May; 9(3):e371. PubMed ID: 31828974
[TBL] [Abstract][Full Text] [Related]
16. Transmembrane protein KIRREL1 regulates Hippo signaling via a feedback loop and represents a therapeutic target in YAP/TAZ-active cancers.
Gu Y; Wang Y; Sha Z; He C; Zhu Y; Li J; Yu A; Zhong Z; Wang X; Sun Y; Lan F; Yu FX
Cell Rep; 2022 Aug; 40(9):111296. PubMed ID: 36044856
[TBL] [Abstract][Full Text] [Related]
17. YAP/TAZ for cancer therapy: opportunities and challenges (review).
Guo L; Teng L
Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
[TBL] [Abstract][Full Text] [Related]
18. Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis.
Boopathy GTK; Hong W
Front Cell Dev Biol; 2019; 7():49. PubMed ID: 31024911
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Hippo Signaling Improves Skin Lesions in a Rosacea-Like Mouse Model.
Lee J; Jung Y; Jeong SW; Jeong GH; Moon GT; Kim M
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477764
[TBL] [Abstract][Full Text] [Related]
20. New insights into the ambivalent role of YAP/TAZ in human cancers.
Luo J; Deng L; Zou H; Guo Y; Tong T; Huang M; Ling G; Li P
J Exp Clin Cancer Res; 2023 May; 42(1):130. PubMed ID: 37211598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
